日韩黄色一级片免费看-丁香婷婷激情五月天综合-日日激情综合久久一区-久久麻豆精亚洲av品国产一区

  設(shè)為主頁 加入收藏 English
 
 
 
 新聞動態(tài)
 行業(yè)動態(tài)
 展會信息
 誠聘英才
 
 

In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma

發(fā)布時間:2017-10-17  點擊次數(shù):319  新聞來源:
 

作者 YanXin Yu, Shan Xu, Hong You, YinJie Zhang, Bo Yang, XiaoYang Sun,

 

 

摘要:In this study, our purpose was to explore the synergistic anti-tumor effect and mechanism of paclitaxel nanoparticles (PTX-NPs) combined with radiotherapy (RT) on human cervical carcinoma (HeLa). PTX-NPs were prepared by a solid dispersion method using methoxy poly(ethylene glycol)–poly(?-caprolactone) (MPEG–PCL), which combined with RT exerted a potent and high efficient effect against cervical cancer. In vivo antitumor activity of PTX-NPs combined with RT, was estimated using nude mice carrying Hela cell xenograft tumor. The results were evaluated using microfluorine-18-deoxyglucose PET/computed tomography (18F-FDG PET/CT) and immunohistochemistry. The results showed that PTX-NPs possessed a more efficient effect than PTX when combined with RT (p<0.05). PTX-NPs in combination with RT might inhibit cell proliferation through its action on Ki-67, and decreased micro-vessel density (MVD) associated with CD31 and vascular endothelial growth factor (VEGF). These results suggested that PTX-NPs possessed a synergistic anti-tumor effect against cervical cancer when combined with RT.

 
 
上海市普陀區(qū)嵐皋路567號1108-26室 電話:021-62665073 400-718-7758 傳真:021-62761957
美國布魯克海文儀器公司上海代表處 版權(quán)所有  管理登陸 ICP備案號:滬ICP備19006074號-2 技術(shù)支持:化工儀器網(wǎng)